# Cephalexin

NDC: 59651-322
Generic name: Cephalexin
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20260609

FDA application: ANDA213568

## Active ingredients

- CEPHALEXIN: 125 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-322"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-322
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=655f38e8-1c4d-4cbc-9f52-bb881f065b2d